We are live on ! Find out more
BIOC

Biocept, Inc.

Delisted

BIOC was delisted on the 24th of October, 2023.

10 hedge funds and large institutions have $1.26M invested in Biocept, Inc. in 2016 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.02% less ownership

Funds ownership: 5%4.97% (-0.02%)

7% less capital invested

Capital invested by funds: $1.36M → $1.26M (-$95K)

17% less funds holding

Funds holding: 1210 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

BIOC Hedge Fund Activity: Q1 2016 in Review

10 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q1 2016, worth a combined $1.26M — down 7% from $1.36M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of BIOC and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Vanguard Group, adding an estimated $114K. The largest seller was Bank of America, exiting entirely with an estimated $40K sold.

  • 10 institutional investors held Biocept, Inc. (BIOC) as of Q1 2016, down from 12 in Q4 2015.
  • Funds reported $1.26M of Biocept, Inc. stock for Q1 2016, down 7% quarter-over-quarter.
  • 0 funds opened new Biocept, Inc. positions in Q1 2016 and 2 closed out, a net change of -2 holders.
  • The largest Biocept, Inc. buyer in Q1 2016 was Vanguard Group, an estimated $114K added.
  • The largest Biocept, Inc. seller in Q1 2016 was Bank of America, an estimated $40K sold.

Based on aggregated 13F filings for Q1 2016.